A better control of the vaccination process against IBDV is possible
16 February 2021
Vaccination against IBDV in hatcheries has become a common practice in poultry since the 90’. The vaccination is performed in-ovo or by subcutaneous injection on the hatch day before the chicks are being placed on farm within a potentially contaminated environment.
It has been demonstrated that IBD prevention at hatchery level can lead to a better vaccine coverage and an increase of the vaccination efficiency. However, there is a particular issue that should be taken into account in this practice:
How can the producers be sure that the chicks have been correctly vaccinated? In other words, how can the hatchery demonstrate that they have vaccinated according to the IBDV protocol?
To address this issue adequately, HIPRA has developed SMART VACCINATION, a completely new and revolutionary concept that helps hatchery managers to control, analyse and certificate their vaccination sessions.
This concept of SMART VACCINATION, that has been completely designed, developed and produced by HIPRA, brings together three interconnected elements: highly innovative vaccines, vaccination tools and vaccination management software.

With SMART VACCINATION, all the vaccination data is automatically collected during the vaccination activity and can be shared with the producer in a total transparent manner.
Through SMART VACCINATION, then, the producer can be totally sure that chicks are vaccinated in the hatchery according to protocol for IBD prevention.
At the present time, the SMART VACCINATION concept is being revitalized with the launch of a new vaccine, GUMBOHATCH®, an innovative immune complex vaccine against Gumboro disease with unique IgY from eggs and specific controls to ensure the complete coating of the IBDV virus.

For GUMBOHATCH®, HIPRA has specifically developed a device for the subcutaneous administration of 0.2 ml with a high level of quality and precision throughout the entire process: Hipraject®.
Besides, HIPRAlink® Vaccination, the third element of the SMART VACCINATION concept, has also been adapted to record all the vaccination data generated by Hipraject®, providing traceability and control for the entire vaccination process. It also helps veterinarians and hatchery managers to manage, analyse and certify their own vaccination activity:
Example of traceability report
Thanks to the concept of SMART VACCINATION and Hipraject®, HIPRA ensures the optimal subcutaneous administration of its new immune complex vaccine against Gumboro disease, GUMBOHATCH®.
Don't miss any updates
Controller: LABORATORIOS HIPRA, S.A.
Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
Lawful basis: Performance of the contractual relationship and HIPRA’s legitimate Interest.
Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.
For further information, please check our detailed information on Data Protection.